Quest Diagnostics Incorporated
Health
Performance
2.1
Risk
Sell
Buy
Curious about the Scores? Learn more.

Quest Diagnostics Incorporated stock rating and score history

All changes in ratings, performance and outlook tracked over time.

16.01.2026
From weak to decent. The first signs are finally showing.
14.01.2026
Short-term strength kicking in. Early signs of life.
27.11.2025
Still low-risk, but small tremors appearing.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.

Quest Diagnostics Incorporated stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Quest Diagnostics Incorporated do? Business model and key facts

Get the full picture of Quest Diagnostics Incorporated: what it builds, where it operates, and how it makes money.

Quest Diagnostics Incorporated Profile

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Employees (FY): 55000

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

shop
Company facts
James E. Davis
CEO
55000
Employees worldwide
shop
Performance
26.56%
Last 12 months
52.95%
Last 5 years
shop
Growth
$9,87B
Revenue year
$921,00M
Net income
shop
Valuation
$21,26B
Market Cap
19.23
Price/Earnings Ratio

Stocks related to Quest Diagnostics Incorporated

Selected based on industry alignment and relative market positioning.

ILMN
Illumina, Inc.
145.30
+0.92%
6.0
Sell
Buy
Illumina, Inc.
WAT
Waters Corporation
394.59
+0.35%
5.5
Sell
Buy
Waters Corporation
MTD
Mettler-Toledo International Inc.
1,496.61
+0.74%
4.7
Sell
Buy
Mettler-Toledo International Inc.
EXAS
Exact Sciences Corporation
102.34
+0.08%
6.8
Sell
Buy
Exact Sciences Corporation
MEDP
Medpace Holdings, Inc.
618.04
+0.26%
4.3
Sell
Buy
Medpace Holdings, Inc.

Quest Diagnostics Incorporated fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.